Please login to the form below

Not currently logged in
Email:
Password:

Firmagon

This page shows the latest Firmagon news and features for those working in and with pharma, biotech and healthcare.

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon. And acknowledges drug's benefits for prostate cancer that spreads to the spine. ... Ferring's Firmagon (degarelix) has been recommended for use by the NHS in England by the country's

Latest news

  • NICE gives partial backing to Ferring's prostate cancer drug NICE gives partial backing to Ferring's prostate cancer drug

    NICE gives partial backing to Ferring's prostate cancer drug. Firmagon on course for use on NHS in England and Wales. ... said. "Patients with pre-existing CVD are most at risk and the evidence shows that Firmagon has a higher chance of reducing that.".

  • Close but no cigar

    Acanya (Arcutis, Dow). Acne vulgaris. US, Europe. Degarelix. FIRMAGON (Ferring). Prostate cancer.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics